Piper Jaffray weighs in on Akorn's (AKRX -6.2%), Q3 report, saying that   guidance for 2012...

|By:, SA News Editor

Piper Jaffray weighs in on Akorn's (AKRX -6.2%), Q3 report, saying that   guidance for 2012 looks conservative and earnings growth should be compelling with the relaunch of up to 20 generic products. The firm reiterates its Overweight rating with a $14 price target.